Aspirin 50332-0139
Product NDC
50332-0139- Manufacturer
- Hart Health
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- January 1, 2023
- Listing Expires
- December 31, 2027
- Application
- M
Active Ingredients
| Ingredient | Strength |
|---|---|
| Aspirin | 325 mg/1 |
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]Anti-Inflammatory Agents
Packaging Options(4)
25 PACKET in 1 BOX, UNIT-DOSE (50332-0139-3) / 2 TABLET in 1 PACKET
50 PACKET in 1 BOX, UNIT-DOSE (50332-0139-4) / 2 TABLET in 1 PACKET
125 PACKET in 1 BOX, UNIT-DOSE (50332-0139-7) / 2 TABLET in 1 PACKET
250 PACKET in 1 BOX, UNIT-DOSE (50332-0139-8) / 2 TABLET in 1 PACKET